Executive Summary

Sorin has rejected Italian press speculation linking it to a acquisition bid for the pharmaceutical company Fidia. The Italian biomedical company has stressed that it has no intention to diversify into the drugs industry. Il Mattino had linked the involvement in the bid of Snia's managing director - and Sorin's previous managing director - Umberto Rosa, to the possible exit of Sorin from Snia (see Clinica No 806, p 7). Snia is the Fiat chemical holding which owns Sorin. Dr Ezio Garibaldi, managing director of the Sorin group, emphasised that there are no plans for Sorin to leave Snia, although Snia may exit Fiat.